Clinical Trials Logo

Femoral Neck Fractures clinical trials

View clinical trials related to Femoral Neck Fractures.

Filter by:

NCT ID: NCT03721835 Terminated - Clinical trials for Femoral Neck Fractures

Safety Study of Femoral Neck Fracture System

CONQUEST FN
Start date: September 10, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the reoperation rate of fractures that have occurred at the neck of the femur that are treated with the CONQUEST FN Femoral Neck Fracture System. The CONQUEST FN Femoral Neck Fracture System is approved for use by the United States Food and Drug Administration (FDA). It consists of a stainless steel plate and up to three (3) screws intended to treat both non-displaced and displaced fractures to the femoral neck.

NCT ID: NCT03695497 Completed - Clinical trials for Femoral Neck Fractures

Direct Anterior Approach for Femoral Neck Fractures

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The primary objective is to examine if in patients with a dislocated femoral neck fracture who receive a total hip arthroplasty, direct anterior approach will give a better result in terms of mobilization, function and pain in the first weeks and months postoperatively, than direct lateral approach.

NCT ID: NCT03666637 Completed - Avascular Necrosis Clinical Trials

Femoral Neck Fracture in Adult and Avascular Necrosis and Nonunion

Start date: September 15, 2017
Phase:
Study type: Observational

One of the most serious sequelae of femoral neck fractures (FNFs) is avascular necrosis (AVN) and nonunion, and this translates to a significant morbidity and mortality. This study was conducted to determine the relationship between the etiologies and management of FNFs in our institution and its relationship to the development of AVN or nonunion.

NCT ID: NCT03550079 Recruiting - Clinical trials for Femoral Neck Fracture

Fixation for the Treatment of Femoral Neck Fractures

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The femoral neck fracture is the most prevalent injuries which commonly encountered among older people with high mortality, morbidity and young fit healthy ones who subjected to high-energy trauma . Non-union or avascular necrosis of femoral neck fracture which lead to loss of labor capacity and death, is the most commonly occurred complication and results in considerable burden for family. The treatment is difficult and challenging, and to minimize the negative results such as limited mobilization or other complications, it is essential to take active prevention and appropriate treatment depending on fracture pattern and patients' characteristics as early as possible. However, current implant selections for femoral neck fractures remain a topic of greater interest and controversy, and vary substantially from each other .

NCT ID: NCT03502018 Completed - Clinical trials for Femoral Neck Fractures

Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty

HEAT
Start date: March 1, 2018
Phase: Phase 4
Study type: Interventional

This study will examine the efficacy of Liposomal Bupivacaine (Exparel) in hip fracture patients undergoing hip hemiarthroplasty for femoral neck fractures through a posterior approach. Post-operative measures will be assessing pain, overall opiate use, delirium, time-to-ambulation and discharge status.

NCT ID: NCT03493893 Completed - Clinical trials for Fractured Neck of Femur

10 Year Review of the Experience of the PFNA ,TFNA the Affixus Nail

Start date: September 2006
Phase:
Study type: Observational

The aim of this study was to investigate the clinical effects of design changes from the use of three different IM nail designs in the management of extracapsular hip fractures.

NCT ID: NCT03442855 Completed - Clinical trials for Rheumatoid Arthritis

Non-Interventional, Multicenter Bicontact® E PMCF Study

Start date: February 1, 2017
Phase:
Study type: Observational

Prospective observational (non-interventional) cohort study, multi-centric in 5 study Centers in Japan to collect short term clinical and radiological results of the cementless Bicontact® E stem in a standard patient population used in routine clinical practice

NCT ID: NCT03428672 Not yet recruiting - Clinical trials for Femoral Neck Fractures

Quantitative Analysis of Global Proteome in Bone Samples From Patients With Osteoporotic and Nonosteoporotic Fracture

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

RATIONALE: Collecting and storing bone samples from patients with osteoporotic and nonosteoporotic fracture to quantitatively analyze the differentially expressed proteins to further explain the relationship between bone iron content and bone mineral density (BMD). PURPOSE: This research study is looking at changes of iron content and differentially expressed proteins in bone samples from patients with osteoporotic and nonosteoporotic. fracture.

NCT ID: NCT03410940 Terminated - Clinical trials for Rheumatoid Arthritis

PMCF Study of the CLS Brevius Stem With Kinectiv Technology

Start date: January 7, 2011
Phase:
Study type: Observational

This study is a multi-center, prospective, non-controlled post-market surveillance study. The primary objective of this study is to confirm the safety and performance of the CLS Brevius stem with Kinectiv technology by obtaining implant survivorship and clinical outcomes data for the commercially available stem.

NCT ID: NCT03407573 Completed - Anemia Clinical Trials

Restrictive vs Liberal Transfusion Strategy on Cardiac Injury in Patients Undergoing Surgery for Fractured Neck Of Femur

RESULT-NOF
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The investigator wishes to see if it is possible to undertake a study comparing blood transfusion at two different levels of anaemia to see which is best for patients. All patients that present to hospital with a broken hip will be able to take part in the study. If they become anaemic during their treatment they will be allocated to either be transfused when their blood count is less that 9 or less than 7. In all patients, we will measure heart damage with a blood test that is very sensitive. The investigator will also collect data on the incidence of heart attacks and other complications.